Rosemont Pharmaceuticals to Acquire Aytu BioPharma in $2.70 All-Cash Tender Offer
Rosemont aims to expand its U.S. specialty pharma presence.
Already have an account? Sign in.
Rosemont aims to expand its U.S. specialty pharma presence.
Be the first to know when deals break, stocks move, or biotech headlines hit.